Vous avez cherché: overview of reporting requirements and tim... (Danois - Portugais)

the participants also gain an overview of the policy-making processes of the ecb .
the participants also gain an overview of the policy-making processes of the ecb .

titel på dokumentet field trials with veterinary vaccines requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products
título field trials with veterinary vaccines requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products

requirements and controls applied to bovine serum (foetal or calf) used in the protection of immunological veterinary medicinal products
requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products

inden for isma findes der en undergruppe ved navn council of reporting dealers (crd), som har ca. loo medlemmer.
no âmbito da isma existe um subgrupo denominado «council of reporting dealers» (crd), que conta com cerca de 100 membros.

field trials with veterinary vaccines requirements and controls applied to bovine serum (foetal or calf) used in the protection of immunological veterinary medicinal products
bovine serum (foetal or calf) used in the

[14] brief overview of the telecoms rating system for the purposes of the broadband stakeholders group, alan roy bradford ceo/voa, 9 june 2003
[14] brief overview of the telecoms rating system for the purposes of the broadband stakeholders group, alan roy bradford ceo/voa, 9 june 2003

title v security requirements and contingency issues article 21 business continuity and contingency procedures in the event of an abnormal external event or any other event which affects the operation of the ssp , the business continuity and contingency procedures described in appendix iv shall apply .
2007d0007 --- pt --- 12.05.2010 --- 003.001 --- 16 ▼b title v security requirements and contingency issues article 21 business continuity and contingency procedures in the event of an abnormal external event or any other event which affects the operation of the ssp , the business continuity and contingency procedures described in appendix iv shall apply .

titel på dokumentet requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:
título requirements and controls applied to bovine serum used in the production of immunological veterinary medicinal products eu requirements for batches with maximum and minimum titre or batch potency for developmental safety and efficacy studies requirements for live recombinant vectored vaccines requirements for compatibility statements for veterinary vaccines harmonisation of requirements for potency and batch consistency of vaccines vich:

denne analyse er i tråd med kommissionens vurdering i "overview of the state of internal control" og med den årlige beretning fra kommissionens interne revisionstjeneste [35].
esta análise coincide com a avaliação que a comissão apresentou no relatório "overview on the state of internal control" e com o relatório anual do serviço de auditoria interna da comissão [35].

-imo-resolution a.851 (20): den internationale søfartsorganisations resolution a.851 (20) med titlen: "general principles for ship reporting systems and ship reporting requirements, including guidelines for reporting incidents involving dangerous goods, harmful substances and/or marine pollutants"
-resolução a.851(20) da omi, a resolução a.851(20) da organização marítima internacional intitulada%quot%general principles for ship reporting systems and ship reporting requirements, including guidelines for reporting incidents involving dangerous goods, harmful substances and/or marine pollutants%quot%;